AA
GSK icon

Ancora Advisors’s GSK GSK Stock Holding History

Ancora Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$293K Buy
5,317
+1,600
+43% +$86.7K 0.01% 629
2025
Q4 		$182K Buy
3,717
+1,094
+42% +$51K ﹤0.01% 762
2025
Q3 		$113K Sell
2,623
-600
-19% -$23.4K ﹤0.01% 840
2025
Q2 		$124K Buy
3,223
+57
+2% +$2.18K ﹤0.01% 831
2025
Q1 		$123K Sell
3,166
-9,805
-76% -$359K ﹤0.01% 814
2024
Q4 		$439K Sell
12,971
-2,989
-19% -$108K 0.01% 549
2024
Q3 		$652K Sell
15,960
-536
-3% -$21.9K 0.01% 458
2024
Q2 		$635K Buy
16,496
+1,054
+7% +$44.3K 0.02% 459
2024
Q1 		$662K Buy
15,442
+599
+4% +$24.7K 0.02% 464
2023
Q4 		$550K Buy
14,843
+1,551
+12% +$55.7K 0.01% 486
2023
Q3 		$482K Buy
13,292
+635
+5% +$22.5K 0.01% 482
2023
Q2 		$451K Buy
12,657
+1,001
+9% +$35.9K 0.01% 486
2023
Q1 		$415K Buy
11,656
+9,129
+361% +$319K 0.01% 506
2022
Q4 		$89K Buy
2,527
+600
+31% +$20K ﹤0.01% 846
2022
Q3 		$57K Sell
1,927
-3
-0.2% -$114 ﹤0.01% 1045
2022
Q2 		$105K Sell
1,930
-1,036
-35% -$57.2K ﹤0.01% 948
2022
Q1 		$161K Hold
2,966
– – ﹤0.01% 863
2021
Q4 		$163K Sell
2,966
-378
-11% -$19.7K ﹤0.01% 873
2021
Q3 		$160K Sell
3,344
-3,552
-52% -$178K ﹤0.01% 842
2021
Q2 		$344K Hold
6,896
– – 0.01% 633
2021
Q1 		$307K Sell
6,896
-160
-2% -$7.26K 0.01% 632
2020
Q4 		$324K Buy
7,056
+1,196
+20% +$54.9K 0.01% 544
2020
Q3 		$276K Hold
5,860
– – 0.01% 553
2020
Q2 		$298K Sell
5,860
-800
-12% -$41K 0.01% 536
2020
Q1 		$315K Sell
6,660
-320
-5% -$17.1K 0.01% 548
2019
Q4 		$410K Hold
6,980
– – 0.02% 534
2019
Q3 		$373K Sell
6,980
-583
-8% -$30K 0.02% 504
2019
Q2 		$379K Sell
7,563
-1,022
-12% -$51.3K 0.02% 467
2019
Q1 		$449K Sell
8,585
-1,128
-12% -$56.4K 0.02% 446
2018
Q4 		$464K Buy
9,713
+240
+3% +$11.8K 0.02% 423
2018
Q3 		$475K Sell
9,473
-2,480
-21% -$126K 0.02% 497
2018
Q2 		$602K Sell
11,953
-1,753
-13% -$88.3K 0.03% 440
2018
Q1 		$670K Buy
13,706
+849
+7% +$39.5K 0.03% 403
2017
Q4 		$570K Sell
12,857
-2,311
-15% -$107K 0.03% 409
2017
Q3 		$770K Buy
15,168
+880
+6% +$44.6K 0.04% 375
2017
Q2 		$770K Buy
14,288
+1,000
+8% +$53.3K 0.05% 352
2017
Q1 		$699K Sell
13,288
-41
-0.3% -$2.08K 0.05% 362
2016
Q4 		$642K Buy
13,329
+5,111
+62% +$252K 0.05% 364
2016
Q3 		$443K Buy
8,218
+800
+11% +$43.9K 0.04% 353
2016
Q2 		$402K Sell
7,418
-33
-0.4% -$1.74K 0.05% 350
2016
Q1 		$378K Buy
7,451
+3,120
+72% +$155K 0.05% 351
2015
Q4 		$218K Sell
4,331
-51
-1% -$2.6K 0.03% 441
2015
Q3 		$211K Buy
+4,382
New +$228K 0.03% 430

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ancora Advisors's GSK Position: Q1 2026 in Review

Ancora Advisors increased its GSK (GSK) stake by 43% in Q1 2026, buying an estimated $86.7K and bringing the position to 5,317 shares worth $293K. The position accounts for 0.01% of the portfolio, ranked #629.

Ancora Advisors first reported a position in GSK in Q3 2015 and has held it in 43 quarters since. The position peaked at $770K in Q3 2017. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Ancora Advisors held 5,317 shares of GSK worth $293K as of Q1 2026.
  • Ancora Advisors bought 1,600 GSK shares in Q1 2026, an estimated $86.7K.
  • GSK made up 0.01% of Ancora Advisors's portfolio in Q1 2026, its #629 holding.
  • Ancora Advisors first reported a position in GSK in Q3 2015 and has held it in 43 quarters since.
  • Ancora Advisors's GSK position peaked at $770K in Q3 2017.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.